Picwell has hopefully been picked well by investors, who have given the firm that aids consumers in selecting health insurance plans over $4 million in new funding.
Bolder Healthcare Solutions has been on an acquisition tear and adds The ROI Companies to its organization. Both firms are in the revenue cycle management business.
SilverVue, a provider of unclear, at least from reading the press release, telehealth and care transition services, has acquired ProMD, which offers communications services between hospitals and recently discharged patients.
Large publisher Elsevier has acquired InferMed, a clinical decision support software and content company, to add to Elsevier's suite of health information products.
CMS' penalties for health care acquired infections in hospitals did not change the rate of such infections; i.e., the policy didn't work, according to research published in an infection control journal.
http://www.ncbi.nlm.nih.gov/pubmed/25732568
Jul132015
Scaling the heights of fishy journalism, the Washington Post reveals that fish oil supplements are a $1.2 billion industry with no scientific evidence of benefits. This story isn't fin-ished yet.
The reform law established and provided funding for community-based non-profit health plans. A GAO report finds that these plans tend to have lower premiums but have had mixed enrollment success. Some have already gone bust.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.